Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A prescriber-level guide to recognizing, grading, and managing adverse events from finasteride and dutasteride, with dosing tables, monitoring schedules, and evidence-based mitigation strategies.
Read clinical reviewA prescriber- and pharmacist-level guide to 5-α reductase inhibitor drug class review, coding, prior authorization strategy, and step-therapy navigation for finasteride and dutasteride.
Read clinical reviewClinical monograph covering the 5-α reductase inhibitor drug class, including finasteride and dutasteride. Mechanism, pharmacokinetics, landmark trials, dosing, adverse effects, and prescribing considerations for BPH and androgenetic alopecia.
Read clinical reviewComplete DDI table for finasteride and dutasteride, with mechanism-based interaction data, prescribing guidance, and clinical pearls at MD/PharmD level.
Read clinical reviewComplete clinical reference for 5-α reductase inhibitors (finasteride, dutasteride): mechanism, indications, dosing, monitoring bundle, adverse effects, drug interactions, and prescribing pearls at MD/PharmD level.
Read clinical reviewA prescriber-level review of 5-α reductase inhibitors (finasteride, dutasteride) across special populations: pregnancy, pediatrics, renal impairment, hepatic impairment, elderly patients, and more. Includes dosing guidance, safety data, and guideline citations.
Read clinical reviewA prescriber-level guide to finasteride vs. Dutasteride: mechanism, isoenzyme coverage, approved indications, dosing, side-effect profiles, and evidence-based selection criteria for BPH and androgenetic alopecia.
Read clinical reviewA clinical reference for prescribers and pharmacists covering finasteride and dutasteride dosing, titration strategies, tapering protocols, and evidence-based algorithms for BPH and androgenic alopecia.
Read clinical review